DATE/TIME
September 25, 10:15 – 10:45 AM EST
TITLE
The Three Cs of CDMO Selection: Capability, Capacity and Cost
SPEAKER
Valdas Jurkauskas, Ph.D., Senior Vice President, Oxia Therapeutics
ABSTRACT
Selecting the right CDMO remains one of the most important decisions a sponsor can make as a program moves from development toward commercialization. In this session, Valdas Jurkauskas will discuss a practical framework for evaluating contract manufacturing partners through three core considerations: capability, capacity and cost. The presentation will look at how sponsors can assess technical fit, manufacturing readiness, supply needs and long-term commercial requirements when building a reliable external manufacturing network.
BIO
Valdas Jurkauskas, Ph.D., is Senior Vice President at Oxia Therapeutics. He specializes in Chemistry, Manufacturing and Controls strategy and the development of global manufacturing networks that support pharmaceutical programs as they move from development toward commercialization. His work focuses on CDMO selection, technology transfer, manufacturing strategy and building supply chains that can meet regulatory, technical and commercial requirements. Jurkauskas earned his Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology and his Bachelor of Science degree in Chemistry from the University of Toronto.
